1. Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study. Issue 20 (12th May 2021) Authors: Joura, Elmar A.; Ulied, Angels; Vandermeulen, Corinne; Rua Figueroa, Milagrosa; Seppä, Ilkka; Hernandez Aguado, Juan José; Ahonen, Anitta; Reich, Olaf; Virta, Miia; Perino, Antonino; Peris Tuser, Merce; Peters, Klaus; Origoni, Massimo; Raspagliesi, Francesco; Tjalma, Wiebren A.A.; Tummers, Philip... Journal: Vaccine Issue: Volume 39:Issue 20(2021) Page Start: 2800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗